Concord Medical Services Files 6-K Report
Ticker: CCM · Form: 6-K · Filed: Jul 31, 2024 · CIK: 1472072
| Field | Detail |
|---|---|
| Company | Concord Medical Services Holdings Ltd (CCM) |
| Form Type | 6-K |
| Filed Date | Jul 31, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
Concord Medical Services (CCM) filed a 6-K, confirming their 20-F reporting and Beijing HQ.
AI Summary
Concord Medical Services Holdings Limited filed a Form 6-K on July 31, 2024, reporting its status as a foreign private issuer. The filing provides their principal executive office address in Beijing, People's Republic of China, and confirms they file annual reports under Form 20-F.
Why It Matters
This filing is a routine update for foreign private issuers, confirming their reporting status and providing essential contact information to investors and regulatory bodies.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically indicate a change in risk.
Key Players & Entities
- Concord Medical Services Holdings Limited (company) — Filer of the 6-K report
- 001-34563 (company) — SEC File Number
- 20240731 (date) — Filing date and period of report
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers filed with the SEC to provide information that the issuer would be required to disclose to its security holders or make public pursuant to the laws of its home country or a foreign stock exchange.
Which form does Concord Medical Services Holdings Limited use for its annual reports?
Concord Medical Services Holdings Limited indicates it files its annual reports under cover of Form 20-F.
Where is Concord Medical Services Holdings Limited's principal executive office located?
The principal executive office of Concord Medical Services Holdings Limited is located at Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020, People's Republic of China.
What is the Commission File Number for Concord Medical Services Holdings Limited?
The Commission File Number for Concord Medical Services Holdings Limited is 001-34563.
What is the filing date of this Form 6-K?
This Form 6-K was filed as of July 31, 2024.
Filing Stats: 362 words · 1 min read · ~1 pages · Grade level 13.3 · Accepted 2024-07-31 08:37:23
Filing Documents
- tm2420542d1_6k.htm (6-K) — 11KB
- 0001104659-24-084167.txt ( ) — 12KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Republic of China (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Concord Healthcare Announces Termination of Voting Proxy Arrangement Concord Healthcare Group Co., Ltd. (“Concord Healthcare”), a subsidiary of Concord Medical Services Holdings Limited (the “Company”) (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the “HKSE”) under the stock code 2453.HK, announced the termination of voting proxy arrangement between Medstar (Shanghai) Financial Leasing Co., Ltd. (“Shanghai Medstar”), a subsidiary of the Company, and five non-controlling shareholders of Concord Healthcare (collectively, the “Proxy Granters”) on July 31, 2024. Each of the Proxy Granters had previously irrevocably delegated its voting rights in the general meeting of shareholders of Concord Healthcare to Shanghai Medstar (collectively, the “Voting Proxy Arrangement”). On July 31, 2024, Shanghai Medstar and the Proxy Granters terminated the Voting Proxy Arrangement upon negotiation in good faith with immediate effect. The Company previously announced the listing of Concord Healthcare’s H shares on the HKSE on January 9, 2024. The information related to Concord Healthcare’s Transactions on the HKSE is accessible through the HKSE’s website at www.hkexnews.hk . SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CONCORD MEDICAL SERVICES HOLDINGS LIMITED By: /s/ Jianyu Yang Name: Jianyu Yang Title: Chairman and Chief Executive Officer Date: July 31, 2024